News • Repairing heart muscle with stem cells

Trial run for tissue engineered 'heart patch'

For the first time, engineered heart muscle (EHM) from human induced pluripotent stem cells (iPSCs) will be used to treat patients with heart failure.

After regulatory approval, recruitment of the first patient for the first-in-class, first-in-patient BioVAT-HF early clinical trial has started in Göttingen, Germany. The trial is sponsored by the University Medical Center Göttingen and funded by the German Center for Cardiovascular Research (DZHK) and the Repairon GmbH. Additional participating centers include the University Medical Center Schleswig-Holstein in Lübeck and the Heart- and Diabetes Center of the Ruhr University of Bochum in Bad Oeynhausen.

Engineered Heart Muscle (EHM)
Source: UMG

Heart failure affects 60 million people worldwide. With current treatment and medical care, one out of five patients with heart failure will die within 12 months – there is no cure. This means that half of those diagnosed with heart failure today will not be alive in 5 years. The BioVAT-HF-DZHK20** Phase I/II clinical trial comes after 25 years of compre-hensive preclinical development, and is the first to investigate whether the implantation of a heart muscle patch, grown in a laboratory from stem cells, can safely and effectively repair the failing heart.

Approval of the BioVAT-HF-DZHK20 multicenter trial was granted by the Paul-Ehrlich-Institute at the end of 2020. The trial is scheduled to enroll 53 patients with advanced heart failure.

Additional information on the trial can be found on (Identifier: NCT04396899)

Source: University Medical Center Göttingen


Read all latest stories

Related articles


News • Cardiology insights

Lab-grown heart cells 'mimic' disease in vitro

Heart cells from a patient with an inherited heart disease called arrhythmogenic cardiomyopathy do not contract correctly when grown in the laboratory, researchers from Osaka University have found.


Video • Transthoracic ultrasound localization microscopy

Super-resolution imaging of microscopic heart vessels

Researchers were able to produce sub-millimetre resolution images of cardiac micro-vessels. This non-invasive new technique could allow scientists to study the physiology of the heart in more detail.


News • Ventricular fibrillation research

Promising therapeutic target for cardiac arrhythmias discovered

A newly discovered signaling mechanism implicated in the development of ventricular fibrillation offers promise of future treatment options for this life threatening condition.

Related products

Subscribe to Newsletter